| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Pelcitoclax | BM-1252; APG-1252 | Phase 2 Clinical | Jiangsu Yasheng Pharmaceutical Development Co Ltd | Solid tumours; Ovarian Neoplasms; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lymphoma, Extranodal NK-T-Cell; Primary Myelofibrosis; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Uterine Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid | 詳細 |
| TGRX-814 | TGRX-814 | Phase 2 Clinical | Hematologic Neoplasms; Leukemia; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma | 詳細 | |
| LP-118 | LP-118 | Phase 2 Clinical | Guangzhou Lupeng Pharmaceutical Co Ltd, Newave Pharmaceutical Inc | Lymphoma, B-Cell; Solid tumours; Leukemia; Bone Marrow Neoplasms; Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Richter's Syndrome; Primary Myelofibrosis; Leukemia, Prolymphocytic, T-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | 詳細 |
| UBX-1325 | UBX-1325 | Phase 2 Clinical | Unity Biotechnology Inc, Ascentage Pharma Group International | Macular Edema; Diabetic macular oedema; Macular Degeneration | 詳細 |
| Mirzotamab clezutoclax | ABBV-155 | Phase 1 Clinical | Abbvie Inc | Solid tumours | 詳細 |
| DT-2216 | DT-2216 | Phase 1 Clinical | University Of Florida, Dialectic Therapeutics Inc | Hematologic Neoplasms; Solid tumours | 詳細 |
| ABBV-637 | ABBV-637 | Phase 1 Clinical | Abbvie Inc | Solid tumours; Carcinoma, Non-Small-Cell Lung | 詳細 |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | オリジナル製品名 | 最初に承認をした国 | 最初の適応症 | 最初に承認を受けた会社 | 承認された日付 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossypol acetic acid/Potassium Chloride/Vitamin B1/Vitamin B6 | Approved | Mainland China | Uterine Hemorrhage; Uterine Neoplasms; Endometriosis | Xi'An Beifang Medicine Co Ltd | 1988-01-01 | Endometriosis; Uterine Hemorrhage; Uterine Neoplasms | 詳細 | |||
| R-(-)-gossypol acetic acid | AT-101; BL-193; TW-37; NSC-726190 | Approved | University Of Michigan, Jiangsu Yasheng Pharmaceutical Development Co Ltd, National Institutes Of Health | Mainland China | Contraception; Genital Diseases, Female | Shanxi Panlong Pharmaceutical Group Limited By Share Ltd | 2002-01-01 | Esophageal Neoplasms; Contraception; Genital Diseases, Female; Glioblastoma; Lymphoma, Large B-Cell, Diffuse; Small Cell Lung Carcinoma; Adrenocortical Carcinoma; Prostatic Neoplasms; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Brain Neoplasms; Gliosarcoma; Leukemia, Lymphocytic, Chronic, B-Cell | 詳細 |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8



